345 related articles for article (PubMed ID: 28108290)
1. Pmp22 mutant allele-specific siRNA alleviates demyelinating neuropathic phenotype in vivo.
Lee JS; Chang EH; Koo OJ; Jwa DH; Mo WM; Kwak G; Moon HW; Park HT; Hong YB; Choi BO
Neurobiol Dis; 2017 Apr; 100():99-107. PubMed ID: 28108290
[TBL] [Abstract][Full Text] [Related]
2. Induced myelination and demyelination in a conditional mouse model of Charcot-Marie-Tooth disease type 1A.
Perea J; Robertson A; Tolmachova T; Muddle J; King RH; Ponsford S; Thomas PK; Huxley C
Hum Mol Genet; 2001 May; 10(10):1007-18. PubMed ID: 11331611
[TBL] [Abstract][Full Text] [Related]
3. Farnesol Ameliorates Demyelinating Phenotype in a Cellular and Animal Model of Charcot-Marie-Tooth Disease Type 1A.
Park NY; Kwak G; Doo HM; Kim HJ; Jang SY; Lee YI; Choi BO; Hong YB
Curr Issues Mol Biol; 2021 Nov; 43(3):2011-2021. PubMed ID: 34889893
[TBL] [Abstract][Full Text] [Related]
4. PMP22 carrying the trembler or trembler-J mutation is intracellularly retained in myelinating Schwann cells.
Colby J; Nicholson R; Dickson KM; Orfali W; Naef R; Suter U; Snipes GJ
Neurobiol Dis; 2000 Dec; 7(6 Pt B):561-73. PubMed ID: 11114256
[TBL] [Abstract][Full Text] [Related]
5. Regulation of Schwann cell proliferation and apoptosis in PMP22-deficient mice and mouse models of Charcot-Marie-Tooth disease type 1A.
Sancho S; Young P; Suter U
Brain; 2001 Nov; 124(Pt 11):2177-87. PubMed ID: 11673320
[TBL] [Abstract][Full Text] [Related]
6. Demyelinating and axonal features of Charcot-Marie-Tooth disease with mutations of myelin-related proteins (PMP22, MPZ and Cx32): a clinicopathological study of 205 Japanese patients.
Hattori N; Yamamoto M; Yoshihara T; Koike H; Nakagawa M; Yoshikawa H; Ohnishi A; Hayasaka K; Onodera O; Baba M; Yasuda H; Saito T; Nakashima K; Kira J; Kaji R; Oka N; Sobue G;
Brain; 2003 Jan; 126(Pt 1):134-51. PubMed ID: 12477701
[TBL] [Abstract][Full Text] [Related]
7. PMP22 overexpression causes dysmyelination in mice.
Robaglia-Schlupp A; Pizant J; Norreel JC; Passage E; Sabéran-Djoneidi D; Ansaldi JL; Vinay L; Figarella-Branger D; Lévy N; Clarac F; Cau P; Pellissier JF; Fontés M
Brain; 2002 Oct; 125(Pt 10):2213-21. PubMed ID: 12244079
[TBL] [Abstract][Full Text] [Related]
8. Rodent models with expression of PMP22: Relevance to dysmyelinating CMT and HNPP.
Jouaud M; Mathis S; Richard L; Lia AS; Magy L; Vallat JM
J Neurol Sci; 2019 Mar; 398():79-90. PubMed ID: 30685714
[TBL] [Abstract][Full Text] [Related]
9. AAV2/9-mediated silencing of PMP22 prevents the development of pathological features in a rat model of Charcot-Marie-Tooth disease 1 A.
Gautier B; Hajjar H; Soares S; Berthelot J; Deck M; Abbou S; Campbell G; Ceprian M; Gonzalez S; Fovet CM; Schütza V; Jouvenel A; Rivat C; Zerah M; François V; Le Guiner C; Aubourg P; Fledrich R; Tricaud N
Nat Commun; 2021 Apr; 12(1):2356. PubMed ID: 33883545
[TBL] [Abstract][Full Text] [Related]
10. Targeting the colony stimulating factor 1 receptor alleviates two forms of Charcot-Marie-Tooth disease in mice.
Klein D; Patzkó Á; Schreiber D; van Hauwermeiren A; Baier M; Groh J; West BL; Martini R
Brain; 2015 Nov; 138(Pt 11):3193-205. PubMed ID: 26297559
[TBL] [Abstract][Full Text] [Related]
11. Analysis of compound heterozygous mice reveals that the Trembler mutation can behave as a gain-of-function allele.
Adlkofer K; Naef R; Suter U
J Neurosci Res; 1997 Sep; 49(6):671-80. PubMed ID: 9335255
[TBL] [Abstract][Full Text] [Related]
12. [Molecular genetics of inherited neuropathies].
Takashima H
Rinsho Shinkeigaku; 2006 Jan; 46(1):1-18. PubMed ID: 16541790
[TBL] [Abstract][Full Text] [Related]
13. Regulation of myelin-specific gene expression. Relevance to CMT1.
Kamholz J; Awatramani R; Menichella D; Jiang H; Xu W; Shy M
Ann N Y Acad Sci; 1999 Sep; 883():91-108. PubMed ID: 10586235
[TBL] [Abstract][Full Text] [Related]
14. A Mutation in PMP2 Causes Dominant Demyelinating Charcot-Marie-Tooth Neuropathy.
Hong YB; Joo J; Hyun YS; Kwak G; Choi YR; Yeo HK; Jwa DH; Kim EJ; Mo WM; Nam SH; Kim SM; Yoo JH; Koo H; Park HT; Chung KW; Choi BO
PLoS Genet; 2016 Feb; 12(2):e1005829. PubMed ID: 26828946
[TBL] [Abstract][Full Text] [Related]
15. Genetic epidemiology of Charcot-Marie-Tooth disease.
Braathen GJ
Acta Neurol Scand Suppl; 2012; (193):iv-22. PubMed ID: 23106488
[TBL] [Abstract][Full Text] [Related]
16. The alpha-chemokine CXCL14 is up-regulated in the sciatic nerve of a mouse model of Charcot-Marie-Tooth disease type 1A and alters myelin gene expression in cultured Schwann cells.
Barbaria EM; Kohl B; Buhren BA; Hasenpusch-Theil K; Kruse F; Küry P; Martini R; Müller HW
Neurobiol Dis; 2009 Mar; 33(3):448-58. PubMed ID: 19111616
[TBL] [Abstract][Full Text] [Related]
17. Overloaded endoplasmic reticulum-Golgi compartments, a possible pathomechanism of peripheral neuropathies caused by mutations of the peripheral myelin protein PMP22.
D'Urso D; Prior R; Greiner-Petter R; Gabreëls-Festen AA; Müller HW
J Neurosci; 1998 Jan; 18(2):731-40. PubMed ID: 9425015
[TBL] [Abstract][Full Text] [Related]
18. Molecular genetics of autosomal-dominant demyelinating Charcot-Marie-Tooth disease.
Houlden H; Reilly MM
Neuromolecular Med; 2006; 8(1-2):43-62. PubMed ID: 16775366
[TBL] [Abstract][Full Text] [Related]
19. Peripheral myelin protein 22 modulates store-operated calcium channel activity, providing insights into Charcot-Marie-Tooth disease etiology.
Vanoye CG; Sakakura M; Follis RM; Trevisan AJ; Narayan M; Li J; Sanders CR; Carter BD
J Biol Chem; 2019 Aug; 294(32):12054-12065. PubMed ID: 31213528
[TBL] [Abstract][Full Text] [Related]
20. Impairment of PMP22 transgenic Schwann cells differentiation in culture: implications for Charcot-Marie-Tooth type 1A disease.
Nobbio L; Vigo T; Abbruzzese M; Levi G; Brancolini C; Mantero S; Grandis M; Benedetti L; Mancardi G; Schenone A
Neurobiol Dis; 2004 Jun; 16(1):263-73. PubMed ID: 15207283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
